<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1.0"><title>Simulated Clinical Trial Dataset — clintrial • fastfit</title><!-- jquery --><script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.7.1/jquery.min.js" integrity="sha512-v2CJ7UaYy4JwqLDIrZUI/4hqeoQieOmAZNXBeQyjo21dadnwR+8ZaIJVT8EE2iyI61OV8e6M8PP2/4hpQINQ/g==" crossorigin="anonymous" referrerpolicy="no-referrer"></script><!-- Bootstrap --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/css/bootstrap.min.css" integrity="sha256-bZLfwXAP04zRMK2BjiO8iu9pf4FbLqX6zitd+tIvLhE=" crossorigin="anonymous"><script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script><!-- bootstrap-toc --><link rel="stylesheet" href="../bootstrap-toc.css"><script src="../bootstrap-toc.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- pkgdown --><link href="../pkgdown.css" rel="stylesheet"><script src="../pkgdown.js"></script><meta property="og:title" content="Simulated Clinical Trial Dataset — clintrial"><meta property="og:description" content="A simulated dataset from a hypothetical multi-center oncology clinical trial
comparing two experimental drugs against control. Designed to demonstrate
the full capabilities of descriptive and regression analysis functions."><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--></head><body data-spy="scroll" data-target="#toc">


    <div class="container template-reference-topic">
      <header><div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">fastfit</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="">0.7.4</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav"><li>
  <a href="../reference/index.html">Reference</a>
</li>
      </ul><ul class="nav navbar-nav navbar-right"><li>
  <a href="https://codeberg.org/phmcc/fastfit/" class="external-link">
    <span class="fas fa-code fa-lg"></span>

  </a>
</li>
      </ul></div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->



      </header><div class="row">
  <div class="col-md-9 contents">
    <div class="page-header">
    <h1>Simulated Clinical Trial Dataset</h1>
    <small class="dont-index">Source: <a href="https://codeberg.org/phmcc/fastfit/src/branch/main/R/data.R" class="external-link"><code>R/data.R</code></a></small>
    <div class="hidden name"><code>clintrial.Rd</code></div>
    </div>

    <div class="ref-description">
    <p>A simulated dataset from a hypothetical multi-center oncology clinical trial
comparing two experimental drugs against control. Designed to demonstrate
the full capabilities of descriptive and regression analysis functions.</p>
    </div>

    <div id="ref-usage">
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="va">clintrial</span></span></code></pre></div>
    </div>

    <div id="format">
    <h2>Format</h2>
    <p>A data frame with 800 observations and 20 variables:</p><dl><dt>patient_id</dt>
<dd><p>Unique patient identifier (character)</p></dd>

  <dt>age</dt>
<dd><p>Age at enrollment in years (numeric: 18-90)</p></dd>

  <dt>sex</dt>
<dd><p>Biological sex (factor: Female, Male)</p></dd>

  <dt>race</dt>
<dd><p>Self-reported race (factor: White, Black, Asian, Other)</p></dd>

  <dt>ethnicity</dt>
<dd><p>Hispanic ethnicity (factor: Non-Hispanic, Hispanic)</p></dd>

  <dt>bmi</dt>
<dd><p>Body mass index in kg/m² (numeric)</p></dd>

  <dt>smoking</dt>
<dd><p>Smoking history (factor: Never, Former, Current)</p></dd>

  <dt>diabetes</dt>
<dd><p>Diabetes diagnosis (factor: No, Yes)</p></dd>

  <dt>hypertension</dt>
<dd><p>Hypertension diagnosis (factor: No, Yes)</p></dd>

  <dt>stage</dt>
<dd><p>Disease stage at diagnosis (factor: I, II, III, IV)</p></dd>

  <dt>grade</dt>
<dd><p>Tumor grade (factor: Well/Moderately/Poorly differentiated)</p></dd>

  <dt>ecog</dt>
<dd><p>ECOG performance status (factor: 0, 1, 2, 3)</p></dd>

  <dt>biomarker_x</dt>
<dd><p>Serum biomarker A in ng/mL (numeric)</p></dd>

  <dt>biomarker_y</dt>
<dd><p>Serum biomarker B in U/L (numeric)</p></dd>

  <dt>hemoglobin</dt>
<dd><p>Baseline hemoglobin in g/dL (numeric)</p></dd>

  <dt>creatinine</dt>
<dd><p>Baseline creatinine in mg/dL (numeric)</p></dd>

  <dt>treatment</dt>
<dd><p>Randomized treatment (factor: Control, Drug A, Drug B)</p></dd>

  <dt>surgery</dt>
<dd><p>Surgical resection (factor: No, Yes)</p></dd>

  <dt>los_days</dt>
<dd><p>Hospital length of stay in days (numeric)</p></dd>

  <dt>site</dt>
<dd><p>Enrolling site (factor: Site_A through Site_J)</p></dd>

  <dt>os_months</dt>
<dd><p>Overall survival time in months (numeric)</p></dd>

  <dt>os_status</dt>
<dd><p>Death indicator (numeric: 0=censored, 1=death)</p></dd>


</dl></div>
    <div id="source">
    <h2>Source</h2>
    <p>Simulated data for demonstration purposes</p>
    </div>
    <div id="details">
    <h2>Details</h2>
    <p>This dataset includes realistic correlations between variables:
- Survival is worse with higher stage, ECOG, age, and biomarker_x
- Treatment effects show Drug B &gt; Drug A &gt; Control
- Approximately 2% of values are missing at random
- Median follow-up is approximately 30 months</p>
    </div>

    <div id="ref-examples">
    <h2>Examples</h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/utils/data.html" class="external-link">data</a></span><span class="op">(</span><span class="va">clintrial</span><span class="op">)</span></span></span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/utils/data.html" class="external-link">data</a></span><span class="op">(</span><span class="va">clintrial_labels</span><span class="op">)</span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># Descriptive statistics by treatment arm</span></span></span>
<span class="r-in"><span><span class="fu"><a href="desctbl.html">desctbl</a></span><span class="op">(</span><span class="va">clintrial</span>,</span></span>
<span class="r-in"><span>        by <span class="op">=</span> <span class="st">"treatment"</span>, </span></span>
<span class="r-in"><span>        variables <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"age"</span>, <span class="st">"sex"</span>, <span class="st">"stage"</span>, <span class="st">"ecog"</span>, </span></span>
<span class="r-in"><span>                     <span class="st">"biomarker_x"</span>, <span class="st">"Surv(os_months, os_status)"</span><span class="op">)</span>,</span></span>
<span class="r-in"><span>        var_labels <span class="op">=</span> <span class="va">clintrial_labels</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                    Variable           Group            Total          Control</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                      &lt;char&gt;          &lt;char&gt;           &lt;char&gt;           &lt;char&gt;</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  1:                       N                              850              183</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  2:             Age (years)       Mean ± SD      59.5 ± 11.4      58.4 ± 11.8</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  3:                            Median [IQR] 59.0 [52.0-68.0] 59.0 [50.5-66.5]</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  4:                                   Range        25.0-90.0        29.0-90.0</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  5:                     Sex          Female      463 (54.5%)       94 (51.4%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  6:                                    Male      387 (45.5%)       89 (48.6%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  7:           Disease Stage               I      229 (27.0%)       50 (27.6%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  8:                                      II      265 (31.3%)       68 (37.6%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  9:                                     III      238 (28.1%)       44 (24.3%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 10:                                      IV      115 (13.6%)       19 (10.5%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 11: ECOG Performance Status               0      248 (29.5%)       59 (32.4%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 12:                                       1      341 (40.5%)       69 (37.9%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 13:                                       2      212 (25.2%)       45 (24.7%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 14:                                       3        41 (4.9%)         9 (4.9%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 15:     Biomarker X (ng/mL)       Mean ± SD        5.2 ± 3.0        5.1 ± 3.1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 16:                            Median [IQR]    4.5 [3.0-6.7]    4.4 [2.8-6.7]</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 17:                                   Range         0.5-19.9         0.5-17.8</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 18:        Overall Survival Median (95% CI) 28.2 (25.1-32.2) 22.0 (18.6-32.4)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>               Drug A           Drug B p-value</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>               &lt;char&gt;           &lt;char&gt;  &lt;char&gt;</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  1:              294              373        </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  2:      59.2 ± 11.1      60.4 ± 11.5   0.137</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  3: 59.0 [52.0-66.0] 60.0 [52.0-69.0]   0.131</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  4:        31.0-90.0        25.0-90.0        </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  5:      160 (54.4%)      209 (56.0%)   0.583</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  6:      134 (45.6%)      164 (44.0%)        </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  7:       74 (25.2%)      105 (28.2%)   0.202</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  8:       94 (32.0%)      103 (27.7%)        </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  9:       80 (27.2%)      114 (30.6%)        </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 10:       46 (15.6%)       50 (13.4%)        </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 11:       87 (29.6%)      102 (27.9%)   0.813</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 12:      126 (42.9%)      146 (39.9%)        </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 13:       69 (23.5%)       98 (26.8%)        </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 14:        12 (4.1%)        20 (5.5%)        </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 15:        5.2 ± 3.0        5.3 ± 2.9   0.862</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 16:    4.6 [3.0-6.6]    4.6 [3.2-6.7]   0.574</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 17:         0.6-19.9         0.6-17.6        </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 18: 44.6 (35.8-57.7) 22.2 (19.3-26.7) &lt; 0.001</span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># Univariable screening</span></span></span>
<span class="r-in"><span><span class="fu"><a href="uscreen.html">uscreen</a></span><span class="op">(</span><span class="va">clintrial</span>,</span></span>
<span class="r-in"><span>        outcome <span class="op">=</span> <span class="st">"Surv(os_months, os_status)"</span>,</span></span>
<span class="r-in"><span>        predictors <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"age"</span>, <span class="st">"sex"</span>, <span class="st">"stage"</span>, <span class="st">"grade"</span>, <span class="st">"ecog"</span>,</span></span>
<span class="r-in"><span>                      <span class="st">"biomarker_x"</span>, <span class="st">"treatment"</span><span class="op">)</span>,</span></span>
<span class="r-in"><span>        model_type <span class="op">=</span> <span class="st">"coxph"</span>,</span></span>
<span class="r-in"><span>        var_labels <span class="op">=</span> <span class="va">clintrial_labels</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Univariable Screening Results</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Outcome: Surv(os_months, os_status)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Model Type: Cox PH</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Predictors Screened: 7</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Significant (p &lt; 0.05): 6</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                    Variable                     Group      n Events</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                      &lt;char&gt;                    &lt;char&gt; &lt;char&gt; &lt;char&gt;</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  1:             Age (years)                         -    850    559</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  2:                     Sex                    Female    463    311</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  3:                                              Male    387    248</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  4:           Disease Stage                         I    229    106</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  5:                                                II    265    164</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  6:                                               III    238    182</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  7:                                                IV    115    105</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  8:             Tumor Grade       Well-differentiated    169     98</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  9:                         Moderately differentiated    407    266</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 10:                             Poorly differentiated    264    189</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 11: ECOG Performance Status                         0    248    126</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 12:                                                 1    341    225</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 13:                                                 2    212    166</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 14:                                                 3     41     38</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 15:     Biomarker X (ng/mL)                         -    842    555</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 16:         Treatment Group                   Control    183    127</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 17:                                            Drug A    294    164</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 18:                                            Drug B    373    268</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     Univariable HR (95% CI) p-value</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                      &lt;char&gt;  &lt;char&gt;</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  1:        1.02 (1.01-1.03) &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  2:               reference       -</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  3:        0.95 (0.81-1.13)   0.579</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  4:               reference       -</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  5:        1.52 (1.19-1.94) &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  6:        2.27 (1.78-2.88) &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  7:        4.04 (3.07-5.30) &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  8:               reference       -</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  9:        1.26 (1.00-1.59)   0.050</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 10:        1.59 (1.24-2.03) &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 11:               reference       -</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 12:        1.56 (1.26-1.94) &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 13:        2.25 (1.78-2.84) &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 14:        3.91 (2.71-5.63) &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 15:        1.08 (1.06-1.11) &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 16:               reference       -</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 17:        0.66 (0.52-0.83) &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 18:        1.09 (0.88-1.35)   0.408</span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># Multivariable model</span></span></span>
<span class="r-in"><span><span class="fu"><a href="fit.html">fit</a></span><span class="op">(</span><span class="va">clintrial</span>,</span></span>
<span class="r-in"><span>    outcome <span class="op">=</span> <span class="st">"Surv(os_months, os_status)"</span>,</span></span>
<span class="r-in"><span>    predictors <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"age"</span>, <span class="st">"stage"</span>, <span class="st">"ecog"</span>, <span class="st">"biomarker_x"</span>, <span class="st">"treatment"</span><span class="op">)</span>,</span></span>
<span class="r-in"><span>    model_type <span class="op">=</span> <span class="st">"coxph"</span>,</span></span>
<span class="r-in"><span>    var_labels <span class="op">=</span> <span class="va">clintrial_labels</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Multivariable Cox PH Model</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Formula: Surv(os_months, os_status) ~ age + stage + ecog + biomarker_x + treatment</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> N = 837, Events = 552</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                    Variable   Group      n Events Multivariable aHR (95% CI)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                      &lt;char&gt;  &lt;char&gt; &lt;char&gt; &lt;char&gt;                     &lt;char&gt;</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  1:             Age (years)       -    837    552           1.02 (1.01-1.03)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  2:           Disease Stage       I    229    106                  reference</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  3:                              II    265    164           1.45 (1.13-1.86)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  4:                             III    238    182           2.46 (1.93-3.14)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  5:                              IV    115    105           5.78 (4.35-7.67)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  6: ECOG Performance Status       0    248    126                  reference</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  7:                               1    341    225           1.88 (1.51-2.35)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  8:                               2    212    166           2.79 (2.20-3.53)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  9:                               3     41     38           4.93 (3.38-7.18)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 10:     Biomarker X (ng/mL)       -    837    552           1.09 (1.06-1.12)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 11:         Treatment Group Control    183    127                  reference</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 12:                          Drug A    294    164           0.48 (0.38-0.61)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 13:                          Drug B    373    268           0.89 (0.72-1.10)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     p-value</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>      &lt;char&gt;</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  1: &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  2:       -</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  3:   0.003</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  4: &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  5: &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  6:       -</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  7: &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  8: &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  9: &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 10: &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 11:       -</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 12: &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 13:   0.288</span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># Complete analysis pipeline</span></span></span>
<span class="r-in"><span><span class="fu"><a href="fastfit.html">fastfit</a></span><span class="op">(</span><span class="va">clintrial</span>,</span></span>
<span class="r-in"><span>        outcome <span class="op">=</span> <span class="st">"Surv(os_months, os_status)"</span>,</span></span>
<span class="r-in"><span>        predictors <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"age"</span>, <span class="st">"sex"</span>, <span class="st">"stage"</span>, <span class="st">"grade"</span>, <span class="st">"ecog"</span>,</span></span>
<span class="r-in"><span>                      <span class="st">"smoking"</span>, <span class="st">"biomarker_x"</span>, <span class="st">"biomarker_y"</span>, <span class="st">"treatment"</span><span class="op">)</span>,</span></span>
<span class="r-in"><span>        method <span class="op">=</span> <span class="st">"screen"</span>,</span></span>
<span class="r-in"><span>        p_threshold <span class="op">=</span> <span class="fl">0.20</span>,</span></span>
<span class="r-in"><span>        model_type <span class="op">=</span> <span class="st">"coxph"</span>,</span></span>
<span class="r-in"><span>        var_labels <span class="op">=</span> <span class="va">clintrial_labels</span><span class="op">)</span></span></span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Running univariable analysis...</span>
<span class="r-msg co"><span class="r-pr">#&gt;</span> Fitting multivariable model with 7 predictors...</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Fastfit Analysis Results</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Outcome: Surv(os_months, os_status)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Model Type: coxph</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Method: screen</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Multivariable predictors: 7</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                    Variable                     Group      n Events</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                      &lt;char&gt;                    &lt;char&gt; &lt;char&gt; &lt;char&gt;</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  1:             Age (years)                         -    850    559</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  2:                     Sex                    Female    463    311</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  3:                                              Male    387    248</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  4:           Disease Stage                         I    229    106</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  5:                                                II    265    164</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  6:                                               III    238    182</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  7:                                                IV    115    105</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  8:             Tumor Grade       Well-differentiated    169     98</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  9:                         Moderately differentiated    407    266</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 10:                             Poorly differentiated    264    189</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 11: ECOG Performance Status                         0    248    126</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 12:                                                 1    341    225</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 13:                                                 2    212    166</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 14:                                                 3     41     38</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 15:          Smoking Status                     Never    374    256</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 16:                                            Former    289    179</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 17:                                           Current    170    114</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 18:     Biomarker X (ng/mL)                         -    842    555</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 19:       Biomarker Y (U/L)                         -    842    555</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 20:         Treatment Group                   Control    183    127</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 21:                                            Drug A    294    164</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 22:                                            Drug B    373    268</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                    Variable                     Group      n Events</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     Univariable HR (95% CI)   Uni p Multivariable aHR (95% CI) Multi p</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                      &lt;char&gt;  &lt;char&gt;                     &lt;char&gt;  &lt;char&gt;</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  1:        1.02 (1.01-1.03) &lt; 0.001           1.02 (1.01-1.03) &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  2:               reference       -                          -       -</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  3:        0.95 (0.81-1.13)   0.579                          -       -</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  4:               reference       -                  reference       -</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  5:        1.52 (1.19-1.94) &lt; 0.001           1.51 (1.18-1.94)   0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  6:        2.27 (1.78-2.88) &lt; 0.001           2.58 (2.01-3.30) &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  7:        4.04 (3.07-5.30) &lt; 0.001           6.23 (4.67-8.31) &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  8:               reference       -                  reference       -</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  9:        1.26 (1.00-1.59)   0.050           1.39 (1.10-1.75)   0.006</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 10:        1.59 (1.24-2.03) &lt; 0.001           1.82 (1.42-2.34) &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 11:               reference       -                  reference       -</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 12:        1.56 (1.26-1.94) &lt; 0.001           1.85 (1.48-2.31) &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 13:        2.25 (1.78-2.84) &lt; 0.001           2.78 (2.19-3.53) &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 14:        3.91 (2.71-5.63) &lt; 0.001           5.16 (3.54-7.54) &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 15:               reference       -                  reference       -</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 16:        0.84 (0.70-1.02)   0.083           0.88 (0.72-1.07)   0.193</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 17:        0.90 (0.72-1.13)   0.370           0.99 (0.80-1.24)   0.962</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 18:        1.08 (1.06-1.11) &lt; 0.001           1.09 (1.06-1.12) &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 19:        1.00 (1.00-1.00)   0.345                          -       -</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 20:               reference       -                  reference       -</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 21:        0.66 (0.52-0.83) &lt; 0.001           0.50 (0.39-0.63) &lt; 0.001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 22:        1.09 (0.88-1.35)   0.408           0.87 (0.70-1.08)   0.208</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     Univariable HR (95% CI)   Uni p Multivariable aHR (95% CI) Multi p</span>
<span class="r-in"><span>        </span></span>
</code></pre></div>
    </div>
  </div>
  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">
    <nav id="toc" data-toggle="toc" class="sticky-top"><h2 data-toc-skip>Contents</h2>
    </nav></div>
</div>


      <footer><div class="copyright">
  <p></p><p>Developed by Paul H. McClelland.</p>
</div>

<div class="pkgdown">
  <p></p><p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.3.</p>
</div>

      </footer></div>






  </body></html>

